North Africa Generic Drug Market to See Striking Growth by 2028 | IMARC Group

According to IMARC Group, the North Africa generic drug market size reached US$ 1.1 Billion in 2022. Looking forward, the market is expected to reach US$ 1.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.97% during 2023-2028.

Factors Affecting the Growth of the North Africa Generic Drug Industry:

• Government Initiatives and Regulatory Support:

The growth of the North Africa generic drug market is significantly influenced by government policies and regulatory support. Many North African governments are implementing reforms to encourage the use of generic drugs, aiming to make healthcare more affordable and accessible. These initiatives include favorable pricing policies, streamlined approval processes for generic drugs, and increased public healthcare spending. Such measures not only stimulate the local generic drug industry but also attract foreign investment, contributing to market growth.

• Increased Demand for Affordable Healthcare:

The rising demand for affordable healthcare solutions is a key driver for the North African generic drug market. With a large proportion of the population in North Africa having limited access to expensive branded medications, there is a growing reliance on more cost-effective generic alternatives. This demand is further fueled by the increasing prevalence of chronic and lifestyle-related diseases, coupled with a growing awareness of generic drugs as a viable and quality alternative to branded medicines.

• Local Manufacturing and Self-sufficiency:

Efforts towards enhancing local manufacturing capabilities significantly influence the North Africa generic drug market. Governments are focusing on reducing dependency on drug imports by fostering domestic pharmaceutical industries. This includes providing incentives for local production, establishing special economic zones, and investing in pharmaceutical R&D. Local production not only ensures a steady supply of affordable medicines but also contributes to the economic development of the region. This shift towards self-sufficiency in drug production is crucial in ensuring long-term stability and growth of the generic drug market in North Africa.

Request for a PDF sample of this report https://www.imarcgroup.com/north-africa-generic-drug-market/requestsample

North Africa Generic Drug Market Report Segmentation: 

Breakup by Segment:

• Unbranded Generics
• Branded Generics

Based on segment, North Africa generic drug market has been divided into unbranded generics and branded generics.

Breakup by Therapy Area:

• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

The central nervous system represents the largest therapy area segment in the North Africa generic drug market due to the high prevalence of neurological disorders in the region and the growing accessibility of affordable generic medications to treat these conditions.

Breakup by Drug Delivery:

• Oral
• Injectables
• Dermal/Topical
• Inhalers

Oral drug formulations dominate the North African generic drug market because of their ease of administration, patient preference, and the cost-effectiveness of producing and distributing oral medications as compared to other delivery methods.

Breakup by Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies

Retail pharmacies are the primary distribution channel in the North African generic drug market, offering widespread and convenient access to a broad range of affordable medications for the general population.

Countries Covered:

• Algeria
• Egypt
• Libya
• Morocco
• Tunisia
• Others

Based on countries, the North Africa generic drug market has been divided into Algeria, Egypt, Libya, Morocco, Tunisia, and Others.

North Africa Generic Drug Market Trends:

The increasing government support and regulatory reforms aimed at promoting generic drug manufacturing and consumption represent one of the key factors influencing the growth of the generic drug market across North Africa. This is driven by the need to enhance healthcare affordability and accessibility in the region which is fueling the market growth. The growing emphasis on local production of generics is contributing to the growth of the market due to the rising initiatives to reduce dependency on imports and strengthen domestic pharmaceutical industries.

The market is also driven by the rising demand for generic drugs attributed to the expanding population and increasing prevalence of chronic diseases like diabetes and hypertension. Cost-effectiveness remains a critical factor, as generics offer a more affordable alternative to branded medications. Furthermore, the market is witnessing a rise in partnerships and collaborations between local and international pharmaceutical companies, aiming to expand product portfolios and leverage regional market insights. Technological advancements and digitalization in healthcare are also influencing the market, improving distribution channels and patient access to generic medicines.

Ask Analyst for Customization and Explore full report with TOC & List of Figures https://www.imarcgroup.com/request?type=report&id=3280&flag=C

Other Key Points Covered in the Report:

• COVID-19 Impact
• Porters Five Forces Analysis
• Value Chain Analysis
• Strategic Recommendation

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com